AHA: Discontinuing statins noninferior to continuation in older adults without known cardiovascular disease
· Medical Xpressby Lori Solomon
edited by Gaby Clark, reviewed by Andrew Zinin
Gaby Clark
Scientific Editor
Meet our editorial team
Behind our editorial process
Andrew Zinin
Chief Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
reputable news agency
proofread
The GIST Add to Preferred Sources
It is generally safe for older adults without a history of cardiovascular disease to discontinue statins for primary prevention, according to a study published online Nov. 7 in the New England Journal of Medicine to coincide with the American Heart Association Scientific Sessions 2026, held from Nov. 6 to 9 in Chicago.
Nicolas Rodondi, M.D., from the University of Bern in Switzerland, and colleagues assessed whether discontinuing statin therapy in older adults with at least two chronic conditions, but no known cardiovascular disease, affects the time to a first cardiovascular event. The analysis included 1,880 participants aged 70 years and older randomly assigned to either discontinue or continue statin therapy and other lipid-lowering therapies.
The researchers found the between-group difference in the restricted mean event-free survival time at two years was −2.0 weeks (P < 0.001 for noninferiority). During a median follow-up of 103 weeks, 12.7% in the discontinuation group and 9.2% in the continuation group experienced a nonfatal myocardial infarction, nonfatal ischemic stroke, or death from any cause. In the discontinuation group, 43.0% of the participants experienced at least one serious adverse event versus 39.8% in the continuation group.
"This small, increased risk of cardiovascular events means that one cannot make a general recommendation about stopping statins in this patient population," co-author Rita F. Redberg, M.D., from the University of California, San Francisco, said in a statement. "There should be shared decision-making between the patient and the health care professional to know if it is appropriate for an individual to discontinue the medication. In general, however, discontinuation is safe for most people who are in this age group and without a previous cardiovascular disease event."
Publication details
Nicolas Rodondi et al., Discontinuing Statins in Older Adults without Cardiovascular Disease, New England Journal of Medicine (2026). DOI: 10.1056/nejmoa2606634
Journal information: New England Journal of Medicine
Key medical concepts
Clinical categories
CardiologyFamily medicine Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
© 2026 HealthDay. All rights reserved.
Citation: AHA: Discontinuing statins noninferior to continuation in older adults without known cardiovascular disease (2026, November 13) retrieved 13 November 2026 from https://medicalxpress.com/news/2026-11-aha-discontinuing-statins-noninferior-older.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.